Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2016 May;74(5):862-9.
doi: 10.1016/j.jaad.2015.12.029. Epub 2016 Feb 18.

Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE)

Affiliations
Comparative Study

Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE)

Janice Tiao et al. J Am Acad Dermatol. 2016 May.

Abstract

Background: Approximately 50% of patients with subacute cutaneous lupus erythematosus (SCLE) meet criteria for systemic lupus erythematosus (SLE). The Systemic Lupus International Collaborating Clinics (SLICC) developed new SLE criteria to improve the American College of Rheumatology (ACR) criteria but the SLICC criteria have not been evaluated in patients with SCLE.

Objective: We sought to determine how patients with SCLE/SLE meet the ACR and SLICC criteria to compare the 2 sets of criteria.

Methods: This was a retrospective analysis of 107 patients with SCLE enrolled in a database at the University of Pennsylvania.

Results: Patients with SCLE/SLE were more likely than those with only SCLE to have oral ulcers, positive anti-double-stranded DNA antibodies, and positive antinuclear antibody test findings using both sets of criteria. Patients with SCLE/SLE were also more likely to have low complement using the SLICC criteria. There was a statistically insignificant increase in individuals meeting the SLICC criteria.

Limitations: Not all patients received comprehensive laboratory testing.

Conclusions: Most patients with SCLE who formally meet criteria for SLE do so based on the laboratory and mucocutaneous criteria. Neither the ACR nor SLICC criteria distinguish patients with SCLE and major internal disease from patients with SCLE without major internal disease.

Keywords: American College of Rheumatology; Systemic Lupus International Collaborating Clinics; classification criteria; cutaneous lupus erythematosus; subacute cutaneous lupus erythematosus; systemic lupus erythematosus.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosure: None Declared

References

    1. Sontheimer RD, Thomas JR, Gillam JN. Subacute cutaneous lupus erythematosus: A cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol. 1979 Dec;115(12):1409–1415. - PubMed
    1. Werth VP. Clinical manifestations of cutaneous lupus erythematosus. Autoimmun Rev. 2005 Jun;4(5):296–302. - PubMed
    1. Rothfield N, Sontheimer RD, Bernstein M. Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol. 2006 Sep-Oct;24(5):348–362. - PubMed
    1. Cohen MR, Crosby D. Systemic disease in subacute cutaneous lupus erythematosus: A controlled comparison with systemic lupus erythematosus. J Rheumatol. 1994 Sep;21(9):1665–1669. - PubMed
    1. Black DR, Hornung CA, Schneider PD, Callen JP. Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus. Arch Dermatol. 2002 Sep;138(9):1175–1178. - PubMed

Publication types

MeSH terms

Substances